Page 201 - Clinical Immunology_ Principles and Practice ( PDFDrive )

182 ParT ONE Principles of Immune Response

33. Hanna S, Etzioni A. Leukocyte adhesion deficiencies. Ann N Y Acad Sci 37. Mackay CR. Moving targets: cell migration inhibitors as new
2012;1250:50–5. anti-inflammatory therapies. Nat Immunol 2008;9:988–98.
34. Steinman L. Immunology of relapse and remission in multiple sclerosis. 38. Rivera-Nieves J. Strategies that target leukocyte traffic in inflammatory
Annu Rev Immunol 2014;32:257–81. bowel diseases: recent developments. Curr Opin Gastroenterol
35. Habtezion A, Nguyen LP, Hadeiba H, et al. Leukocyte trafficking 2015;31:441–8.
to the small intestine and colon. Gastroenterology 2016;150: 39. Calabrese LH, Molloy E, Berger J. Sorting out the risks in progressive
340–54. multifocal leukoencephalopathy. Nat Rev Rheumatol 2015;11:119–23.
36. Peske JD, Woods AB, Engelhard VH. Control of CD8 T-cell infiltration 40. Brinkmann V, Billich A, Baumruker T, et al. Fingolimod (FTY720):
into tumors by vasculature and microenvironment. Adv Cancer Res discovery and development of an oral drug to treat multiple sclerosis. Nat
2015;128:263–307. Rev Drug Discov 2010;9:883–97.